0806 ET - Tilray Brands, whose cannabis and drinks business straddles Canada and the U.S., says it doesn't anticipate a hit to sales from import tariffs after it conducted an analysis of the potential implications on its business. In the U.S., Tilray says its American beverage brands are solely manufactured and distributed within the U.S. market. In Canada, Tilray's cannabis brands are produced domestically for Canadian consumers. in Europe, Tilray manufactures medical cannabis brands and products for distribution across Europe and Australia. Chairman and CEO Irwin Simon says there continues to be opportunities in the alcohol, cannabis, and wellness industries. Tilray also sees a future in digital currencies and plans to accept cryptocurrency as a payment method online and says it is exploring strategic initiatives related to cryptocurrency. (robb.stewart@wsj.com)
(END) Dow Jones Newswires
April 08, 2025 08:06 ET (12:06 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.